
Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study.
Publication
, Journal Article
Johnston, DT; Busse, PJ; Riedl, MA; Maurer, M; Anderson, J; Nurse, C; Inhaber, N; Yu, M; Banerji, A; HELP Study Investigators,
Published in: Clin Exp Allergy
October 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Exp Allergy
DOI
EISSN
1365-2222
Publication Date
October 2021
Volume
51
Issue
10
Start / End Page
1391 / 1395
Location
England
Related Subject Headings
- Quality of Life
- Humans
- Antibodies, Monoclonal, Humanized
- Angioedemas, Hereditary
- Allergy
- 1117 Public Health and Health Services
- 1111 Nutrition and Dietetics
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Johnston, D. T., Busse, P. J., Riedl, M. A., Maurer, M., Anderson, J., Nurse, C., … HELP Study Investigators, . (2021). Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study. Clin Exp Allergy, 51(10), 1391–1395. https://doi.org/10.1111/cea.13974
Johnston, Douglas T., Paula J. Busse, Marc A. Riedl, Marcus Maurer, John Anderson, Christina Nurse, Neil Inhaber, Ming Yu, Aleena Banerji, and Aleena HELP Study Investigators. “Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study.” Clin Exp Allergy 51, no. 10 (October 2021): 1391–95. https://doi.org/10.1111/cea.13974.
Johnston DT, Busse PJ, Riedl MA, Maurer M, Anderson J, Nurse C, et al. Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study. Clin Exp Allergy. 2021 Oct;51(10):1391–5.
Johnston, Douglas T., et al. “Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study.” Clin Exp Allergy, vol. 51, no. 10, Oct. 2021, pp. 1391–95. Pubmed, doi:10.1111/cea.13974.
Johnston DT, Busse PJ, Riedl MA, Maurer M, Anderson J, Nurse C, Inhaber N, Yu M, Banerji A, HELP Study Investigators. Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study. Clin Exp Allergy. 2021 Oct;51(10):1391–1395.

Published In
Clin Exp Allergy
DOI
EISSN
1365-2222
Publication Date
October 2021
Volume
51
Issue
10
Start / End Page
1391 / 1395
Location
England
Related Subject Headings
- Quality of Life
- Humans
- Antibodies, Monoclonal, Humanized
- Angioedemas, Hereditary
- Allergy
- 1117 Public Health and Health Services
- 1111 Nutrition and Dietetics
- 1107 Immunology